Prospective Study of Annual Whole-Body Magnetic Resonance Imaging as Part of a Multimodality Screening Program for Individuals With Li-Fraumeni Syndrome
JCO Precision Oncology · 2025
DOI: 10.1200/po-25-00264 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Precision Oncology, 2025. Verfasst von Asaf Maoz und 21 weiteren Autor:innen. Beteiligte Einrichtung: Dana-Farber Cancer Institute, Boston, MA. Hauptthemen laut MEDLINE: Li-Fraumeni Syndrome, Magnetic Resonance Imaging, Whole Body Imaging, Early Detection of Cancer. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
PURPOSE Individuals with Li-Fraumeni syndrome (LFS) are at risk of developing cancer in multiple organs and therefore require a multimodal screening program. We assessed the performance of annual whole-body noncontrast magnetic resonance imaging (WBMRI) in early cancer detection for individuals with LFS. METHODS Individuals with a germline pathogenic or likely pathogenic variant in the TP53 gene (defined as LFS) and without cancer diagnosed or treated in the preceding 6 months were eligible to undergo annual noncontrast WBMRI. Clinical findings on WBMRI, follow-up studies, biopsies, and cancer incidence were prospectively assessed. RESULTS One hundred sixty-two participants with LFS (127 adult, 35 pediatric) underwent 477 WBMRIs; 119 (73%) underwent three or more. The median age at enrollment was 37 years; 75% of participants were female. Classic or Chompret diagnostic criteria for LFS were met for 68.5% of participants. Follow-up studies for findings on WBMRI were pursued for 55.6% of participants. Biopsies were performed in 18% of participants; 39.5% of 38 biopsies confirmed a cancer diagnosis. The rate of follow-up interventions decreased with consecutive WBMRIs. During the study period, of 37 cancers diagnosed in 33 participants, 15 (40.5%) were diagnosed by WBMRI; 86% (13 of 15) were asymptomatic, localized cancers treated with curative intent. The 22 cancers not diagnosed on WBMRI included five sarcomas; one each of adrenocortical, lung, thyroid, and renal cell carcinomas; and 13 cancers that WBMRI would not be expected to detect. CONCLUSION Annual WBMRI contributes substantially to the detection of asymptomatic localized cancers among individuals with LFS and is best used in conjunction with a multimodality approach endorsed by LFS guidelines. Our study highlights the need for further research to enhance early detection and interception of cancer in LFS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Dana-Farber Cancer Institute, Boston, MA.
- Harvard Medical School, Boston, MA.
- Boston Children's Hospital, Boston, MA.
- University of Texas Southwestern Medical Center, Dallas, TX.
- Brigham and Women's Hospital, Boston, MA.
- Memorial Sloan Kettering Cancer Center, New York, NY.
ORCID-Profile: Asaf Maoz, Puja Umaretiya, Sophie R Cahill, Alison Schwartz-Levine, Stephan D Voss, Danielle N Friedman, Mark E Robson, Megan N Frone, Jaclyn M Schienda, Junne Kamihara, Huma Q Rana, Judy E Garber, Wendy B London, Allison F O'Neill
Förderung
- NCI NIH HHS
Zitieren
APA
Maoz, A., Chen, N., Umaretiya, P., Cahill, S. R., Schwartz-Levine, A., Jagannathan, J., Voss, S. D., Friedman, D. N., Walsh, M., Robson, M. E., Nehoray, B., Frone, M. N., Schneider, K. A., Schienda, J. M., Hamilton, K. V., Onufrychuk, A., Diller, L. R., Kamihara, J., Rana, H. Q., …, & O'Neill, A. F. (2025). Prospective Study of Annual Whole-Body Magnetic Resonance Imaging as Part of a Multimodality Screening Program for Individuals With Li-Fraumeni Syndrome. JCO Precision Oncology. https://doi.org/10.1200/po-25-00264
Vancouver
Maoz A, Chen N, Umaretiya P, Cahill SR, Schwartz-Levine A, Jagannathan J, et al. Prospective Study of Annual Whole-Body Magnetic Resonance Imaging as Part of a Multimodality Screening Program for Individuals With Li-Fraumeni Syndrome. JCO Precision Oncology. 2025. doi:10.1200/po-25-00264
BibTeX
@article{Maoz2025,
author = {Maoz, Asaf and Chen, Nan and Umaretiya, Puja and Cahill, Sophie R and Schwartz-Levine, Alison and Jagannathan, Jyothi and Voss, Stephan D and Friedman, Danielle N and Walsh, Michael and Robson, Mark E and Nehoray, Bita and Frone, Megan N and Schneider, Katherine A and Schienda, Jaclyn M and Hamilton, Kayla V and Onufrychuk, Andrea and Diller, Lisa R and Kamihara, Junne and Rana, Huma Q and Garber, Judy E and London, Wendy B and O'Neill, Allison F},
title = {Prospective Study of Annual Whole-Body Magnetic Resonance Imaging as Part of a Multimodality Screening Program for Individuals With Li-Fraumeni Syndrome},
journal = {JCO Precision Oncology},
year = {2025},
doi = {10.1200/po-25-00264}
}
EUVIMED